GlassScriptPhysician profile
Kelly H Host
NPI 1861698664
$2,589.22
in general payments reported to CMS, 2019-2025
28 companies · $448 in 2025
The $448 reported for 2025 was more than what 84% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $663 · 2022: $635 · 2023: $429 · 2024: $414 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,291.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $459.24 | 2021-2023 | |
| Organon LLC | $344.41 | 2021-2025 | Nexplanon |
| Myovant Sciences INC. | $255.93 | 2021-2022 | |
| Astellas Pharma US INC | $228.83 | 2021-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $210.44 | 2021-2025 | Slynd |
| Daiichi Sankyo INC. | $169.05 | 2022-2025 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $153.70 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $91.23 | 2023 | Myfembree |
| Shield Therapeutics INC | $70.70 | 2023-2025 | Accrufer |
| Millicent US INC | $67.23 | 2024-2025 | Intrarosa, Femring |
| Hologic Sales and Service, LLC | $54.66 | 2021-2024 | Aptima |
| Agile Therapeutics, INC. | $50.33 | 2021-2023 | Twirla |
| Teleflex LLC | $49.92 | 2022 | |
| Therapeuticsmd, INC. | $46.29 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $41.48 | 2022-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $41.43 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Lupin INC. | $32.78 | 2021 | |
| Novo Nordisk INC | $28.89 | 2025 | Wegovy |
| Pfizer INC. | $28.78 | 2021 | |
| Amgen INC. | $27.22 | 2024 | Prolia, Evenity |
| Coopersurgical, INC. | $23.32 | 2025 | Paragard T 380a |
| Biogen, INC. | $22.10 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $16.79 | 2022 | |
| Abbott Laboratories | $16.64 | 2022 | |
| Minerva Surgical, INC | $16.36 | 2024 | |
| Exact Sciences Corporation | $15.31 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $14.57 | 2021 | |
| Aspira Women'S Health INC | $11.59 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Host listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.